This session will be a series of presentations related to analytics and release assays critical to successful implementation of CM. The session will include perspectives on emerging approaches for assessment of quality attributes, on release testing, and on the importance of process control and PAT.
Head of Design, Technology & Standards, Biologics Engineering,
Staff Fellow, Chemist, Office of Testing & Research,
Head of Microbiological Control for Biologic Drugs,